Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Mats Gåfvels"'
Publikováno v:
Adipocyte, Vol 9, Iss 1, Pp 587-599 (2020)
The aim of this study was to elucidate mechanisms whereby bile acids exert beneficial metabolic effects, using the Cyp8b1−/- mouse as model. These mice are unable to synthesize cholic acid, resulting in increased synthesis of chenodeoxycholic acid
Externí odkaz:
https://doaj.org/article/9549d762753c455fb19f23e46f6507ca
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 680-682 (2020)
Heterophilic antibodies but also M-components can interfere with laboratory tests causing erroneous results. We report the case of a 75-year-old man with myeloma and a monoclonal immunoglobulin component (M-component) that caused elevated thyroid-sti
Externí odkaz:
https://doaj.org/article/9e4d477eaa0e4a6d93b5314387ab4793
Autor:
Katharina Slätis, Mats Gåfvels, Kristina Kannisto, Olga Ovchinnikova, Gabrielle Paulsson-Berne, Paolo Parini, Zhao-Yan Jiang, Gösta Eggertsen
Publikováno v:
Journal of Lipid Research, Vol 51, Iss 11, Pp 3289-3298 (2010)
To investigate the effects of abolished cholic acid (CA) synthesis in the ApoE knockout model [apolipoprotein E (apoE) KO],a double-knockout (DKO) mouse model was created by crossbreeding Cyp8b1 knockout mice (Cyp8b1 KO), unable to synthesize the pri
Externí odkaz:
https://doaj.org/article/2a42163791864cfeb2ef25f6ea7011bc
Autor:
Anna Aminoff, Helena Ledmyr, Petra Thulin, Kerstin Lundell, Leyla Nunez, Elisabeth Strandhagen, Charlotte Murphy, Ulf Lidberg, Jukka Westerbacka, Anders Franco-Cereceda, Jan Liska, Lars Bo Nielsen, Mats Gåfvels, Maria Nastase Mannila, Anders Hamsten, Hannele Yki-Järvinen, Dag Thelle, Per Eriksson, Jan Borén, Ewa Ehrenborg
Publikováno v:
Journal of Lipid Research, Vol 51, Iss 1, Pp 103-111 (2010)
Promoter polymorphisms in microsomal triglyceride transfer protein (MTTP) have been associated with decreased plasma lipids but an increased risk for ischemic heart disease (IHD), indicating that MTTP influences the susceptibility for IHD independent
Externí odkaz:
https://doaj.org/article/80621397cadc4995a25c7794e779b1af
Autor:
Lennart Nilsson, Mats Gåfvels, Leena Musakka, Katharina Ensler, Dudley K. Strickland, Bo Angelin, Anders Hamsten, Per Eriksson
Publikováno v:
Journal of Lipid Research, Vol 40, Iss 5, Pp 913-919 (1999)
The potential role of the very low density lipoprotein (VLDL) receptor in mediating VLDL-induced plasminogen activator inhibitor-1 (PAI-1) expression was studied in vitro. Cultured endothelial cells incubated with VLDL showed an increased secretion o
Externí odkaz:
https://doaj.org/article/7f34a73bfa334f6f9e9759ac046c73d9
Autor:
Jordi Magrané, Manuel Reina, Roser Pagan, Ana Luna, Ricardo P. Casaroli-Marano, Bo Angelin, Mats Gåfvels, Senén Vilaró
Publikováno v:
Journal of Lipid Research, Vol 39, Iss 11, Pp 2172-2181 (1998)
The very low density lipoprotein (VLDL) receptor is a member of the low density lipoprotein supergene family of receptors in which differential splicing of mRNA has been reported. We present several lines of evidence showing that bovine aortic endoth
Externí odkaz:
https://doaj.org/article/3a79e5a6c18141f19e4b7076233703ba
Autor:
Xiaoshan Zhou, Kristina Kannisto, Sophie Curbo, Ulrika von Döbeln, Kjell Hultenby, Sindra Isetun, Mats Gåfvels, Anna Karlsson
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58843 (2013)
Thymidine kinase 2 (TK2) deficiency in humans causes mitochondrial DNA (mtDNA) depletion syndrome. To study the molecular mechanisms underlying the disease and search for treatment options, we previously generated and described a TK2 deficient mouse
Externí odkaz:
https://doaj.org/article/9787da95e85c440cbb2d9352b7d0c161
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 2, Pp 680-682 (2020)
Case Reports in Oncology, Vol 13, Iss 2, Pp 680-682 (2020)
Heterophilic antibodies but also M-components can interfere with laboratory tests causing erroneous results. We report the case of a 75-year-old man with myeloma and a monoclonal immunoglobulin component (M-component) that caused elevated thyroid-sti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e5f8d2de4237761a08ad20127d35445
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-416185
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-416185
Autor:
Valgardur, Sigurdsson, Youichi, Haga, Hajime, Takei, Els, Mansell, Chizuko, Okamatsu-Haga, Mitsuyoshi, Suzuki, Visnja, Radulovic, Mark, van der Garde, Shuhei, Koide, Svetlana, Soboleva, Mats, Gåfvels, Hiroshi, Nittono, Akira, Ohara, Kenichi, Miharada
Publikováno v:
Blood Adv
Chemotherapeutic agents can reduce bone marrow (BM) activity, causing myelosuppression, a common life-threatening complication of cancer treatment. It is challenging to predict the patients in whom prolonged myelosuppression will occur, resulting in
Autor:
Mats Gåfvels, Carl Jorns, Kristina Kannisto, X. Hu, Katharina Slätis, Zhao-Yan Jiang, Knut R. Steffensen, Gösta Eggertsen
Publikováno v:
Lipids. 49:71-83
We investigated whether: (1) liver X receptor (LXR)-driven induction of high-density lipoprotein cholesterol (HDL-C) and other LXR-mediated effects on cholesterol metabolism depend on intestinal cholesterol absorption; and (2) combined treatment with